Drug costs to patients too high and complex: Consumers Health Forum

The Grattan Institute report into pharmaceutical premium pricing policy highlights “unnecessarily high” costs to patients and taxpayers of a health system it describes as complex and labyrinthine, says the Consumers Health Forum CEO, Leanne Wells. “We accept the drug industry’s need for a reasonable profit to develop new drugs, but this report exposes a pricing